Copyright
©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3168-3184
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3168
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3168
Figure 3 Conversion therapy model for unresectable hepatocellular carcinoma patients accepted conversion therapy.
A: A constructed nomogram for predicting 1-, 2-, 3-year overall survival; B: Screenshot of the online individualized prediction tool based on the overall survival nomogram model. OS: Overall survival; MVI: Macrovascular invasion; BUN: Blood urea nitrogen; GPR: Gamma-glutamyl transpeptidase to platelet ratio; PLR: Platelet to lymphocyte ratio.
- Citation: Wu JL, Luo JY, Jiang ZB, Huang SB, Chen GR, Ran HY, Liang QY, Huang MS, Lai LS, Chen JW. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy. World J Gastroenterol 2023; 29(20): 3168-3184
- URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3168.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i20.3168